ArticleOncogene2017

Acquired CDK6 amplification promotes breast cancer resistance to CDK4/6 inhibitors and loss of ER signaling and dependence.

C Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.